G0103 HCPCS code: Prostate cancer screening; prostate specific antigen test (PSA)
G0103 is the HCPCS Level II code for prostate cancer screening; prostate specific antigen test (PSA). In 2024 Medicare paid an average of $18.88 per service for G0103 across 1,406,946 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume rose 3% from 2022 to 2024 (1,371,602 to 1,406,946 services). In 2024, about 17,265 clinicians billed Medicare for G0103 for 1,406,924 beneficiaries; Texas, North Carolina, Florida accounted for 29% of services.
Code details
| Field | Value |
|---|---|
| Section | G codes — Procedures and professional services (temporary) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 21 — Priced on the Clinical Laboratory Fee Schedule |
| BETOS category | T1H |
| Added | 2000-01-01 |
| Last action effective | 2007-01-01 |
Who bills G0103 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 17,265 |
| Medicare beneficiaries | 1,406,924 |
| States with claims | 54 |
| Share of services in top 3 states (Texas, North Carolina, Florida) | 29% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for G0103, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,371,602 | 1,371,596 | $19.01 | $19.01 |
| 2023 | 1,382,647 | 1,382,635 | $18.87 | $18.87 |
| 2024 | 1,406,946 | 1,406,924 | $18.88 | $18.88 |
States with the most G0103 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 152,037 | $18.90 |
| North Carolina | 133,473 | $18.90 |
| Florida | 117,579 | $18.88 |
| New Jersey | 100,139 | $18.87 |
| California | 90,448 | $18.91 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Anatomic Consideration |
| practitioner claims | 1 | Anatomic Consideration |
What changed for G0103
- 2000-01-01: G0103 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code G0103?
G0103 is the HCPCS Level II code for prostate cancer screening; prostate specific antigen test (PSA). Short descriptor: "Psa screening".
How much does Medicare pay for G0103?
In 2024, the average Medicare payment was $18.88 per service (average allowed $18.88).
Does Medicare cover G0103?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of G0103 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related G01 codes
- G0101 — Cervical or vaginal cancer screening; pelvic and clinical breast examination
- G0102 — Prostate cancer screening; digital rectal examination
- G0104 — Colorectal cancer screening; flexible sigmoidoscopy
- G0105 — Colorectal cancer screening; colonoscopy on individual at high risk
- G0106 — Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema
- G0108 — Diabetes outpatient self-management training services, individual, per 30 minutes
- G0109 — Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes
- G0117 — Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist
- G0118 — Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist
- G0120 — Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.
- G0121 — Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
- G0122 — Colorectal cancer screening; barium enema
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under G0103
- Watch G0103 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for G0103
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.